Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630109 · ClinicalTrials.gov registry record · Phase 4
Study of Metoclopramide in Small Bowel Capsule Endoscopy
A Phase 4 study, sponsored by Ascension Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT01630109 is a Phase 4 study that has completed, run by Ascension Health. The registered enrollment target is 5 participants.
The verdict
NCT01630109, a Phase 4 study, has completed, sponsored by Ascension Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Patients undergoing small bowel capsule endoscopy will be randomized into 3 study groups to either receive 5 mg of metoclopramide, 10 mg of metoclopramide, or a placebo 30 minutes prior to swallowing the Pill Cam. This is a randomized, double-blind, placebo-controlled design. The outcomes to be assessed are capsule study completion rates, gastric transit time, small bowel transit time, and the effect of diabetes on pill capsule completion rates. The purpose of the study is to assess if metoclopramide given prior to pill capsule endoscopy has any effect on pill capsule completion rate, gastric transit time, small bowel transit time, and pill capsule completion rates in diabetes.
Interventions
- DRUG Placebo
- DRUG Metoclopramide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01630109
The ClinicalTrials.gov registry entry for NCT01630109 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascension Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01630109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01630109 about?
NCT01630109 is a clinical study titled "Study of Metoclopramide in Small Bowel Capsule Endoscopy". Patients undergoing small bowel capsule endoscopy will be randomized into 3 study groups to either receive 5 mg of metoclopramide, 10 mg of metoclopramide, or a placebo 30 minutes prior to swallowing the Pill Cam. This is a randomized, double-blind, placebo-controlled design. The outcomes to be asse...
What is the current status of trial NCT01630109?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2012-12. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01630109?
The interventions under investigation include: Placebo (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT01630109?
This trial is sponsored by Ascension Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.